STABILITY OF CIPROFLOXACIN INJECTION IN PERITONEAL-DIALYSIS SOLUTIONS

被引:5
|
作者
KANE, MP
BAILIE, GR
MOON, DG
SIU, I
机构
[1] Albany College of Pharmacy, Union University, Albany, NY 12208
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1994年 / 51卷 / 03期
关键词
ADDITIVES; CALORIC AGENTS; CIPROFLOXACIN; DEXTROSE; DIALYSIS; INCOMPATIBILITIES; QUINOLONES; STABILITY; STORAGE; TEMPERATURE;
D O I
10.1093/ajhp/51.3.373
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of ciprofloxacin 25 mg/L in peritoneal dialysis solutions containing 1.5% and 4.25% dextrose after storage at 4 degrees C for two weeks, 25 degrees C for one week, or 37 degrees C for two days was evaluated. Ciprofloxacin 50 mg was added to 18 2-L bags of peritoneal dialysis solutions, nine containing 1.5% dextrose and nine containing 4.25% dextrose. Three bags of each dialysis solution were stored at 4 degrees C for 14 days, 25 degrees C for 7 days, and 37 degrees C for 2 days. Samples were drawn from each bag, and ciprofloxacin concentrations were measured by high-performance liquid chromatography. Stability was defined as less than 10% decrease from initial concentration. In the solution containing 1.5% dextrose, 87.2% of the ciprofloxacin remained after 14 days of storage at 4 degrees C, 93.4% remained after 7 days of storage at 25 degrees C, and 95.2% remained after 2 days of storage at 37 degrees C. In the solution containing 4.25% dextrose, 89.0% of the ciprofloxacin remained after 14 days of storage at 4 degrees C, 93.7% remained after 7 days of storage at 25 degrees C, and 97.8% remained after 2 days of storage at 37 degrees C. In peritoneal dialysis solutions containing 1.5% and 4.25% dextrose, ciprofloxacin was stable for seven days at 25 degrees C and for 48 hours at 37 degrees C. Ciprofloxacin concentrations after two weeks at 4 degrees C were below 90% of initial concentration.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [1] STABILITY OF CIPROFLOXACIN IN PERITONEAL-DIALYSIS SOLUTION
    MAWHINNEY, WM
    ADAIR, CG
    GORMAN, SP
    MCCLURG, B
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (12): : 2956 - 2959
  • [2] STABILITY OF OFLOXACIN IN PERITONEAL-DIALYSIS SOLUTIONS
    BATTISTA, C
    KANE, MP
    MOON, DG
    BAILIE, GR
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1995, 15 (01): : 72 - 74
  • [3] STABILITY OF CEFAZOLIN SODIUM IN PERITONEAL-DIALYSIS SOLUTIONS
    NAHATA, MC
    AHALT, PA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (02): : 291 - 292
  • [4] STABILITY OF DOBUTAMINE HYDROCHLORIDE IN PERITONEAL-DIALYSIS SOLUTIONS
    GORA, ML
    SETH, S
    VISCONTI, JA
    SHIELDS, B
    BAY, W
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (06): : 1234 - 1237
  • [5] STABILITY OF COMBINATIONS OF ANTIBIOTICS IN PERITONEAL-DIALYSIS SOLUTIONS
    WEIJERS, TF
    FIEREN, MWJA
    WAGENVOORT, JHT
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (01): : 52 - 53
  • [6] STABILITY OF CEFTRIAXONE SODIUM IN PERITONEAL-DIALYSIS SOLUTIONS
    NAHATA, MC
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (7-8): : 741 - 742
  • [7] STABILITY OF CEFOTAXIME IN 2 PERITONEAL-DIALYSIS SOLUTIONS
    PAAP, CM
    NAHATA, MC
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (01): : 147 - 150
  • [8] CIPROFLOXACIN PENETRATION INTO PERITONEAL-DIALYSIS FLUID
    FLEMING, LW
    MORELAND, TA
    SCOTT, AC
    STEWART, WK
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (05) : P653 - P654
  • [9] PERITONEAL-DIALYSIS SOLUTIONS
    OREOPOULOS, DG
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (02): : 70 - 71
  • [10] PERITONEAL-DIALYSIS SOLUTIONS
    GAULT, MH
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1973, 108 (03) : 325 - 327